Showing results (221-230 of 236) with videos related to
Sort By:
Pageof 24
Thrombosis Research|April 24, 2017
Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trialYihong Sun, Dayi Hu, Susanna Stevens, et al.Circulation|March 31, 2004
Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndromePeter J Schwartz, Silvia G Priori, Marina Cerrone, et al.European Journal of Heart Failure|March 11, 2015
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registryGerasimos Filippatos, Sadiya Sana Khan, Andrew P Ambrosy, et al.Circulation. Cardiovascular Quality and Outcomes|March 13, 2014
Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trialXin Du, Runlin Gao, Fiona Turnbull, et al.Circulation Research|August 31, 2012
Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarctionEnrico Ammirati, Carlo V Cannistraci, Nicole A Cristell, et al.Circulation|September 1, 2016
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.Zhonghua Nei Ke Za Zhi|February 19, 2016
[The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia]Xin Liu, Wenling Liu, Dayi Hu, et al.The Lancet. Diabetes & Endocrinology|December 26, 2015
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional studyXiaoxu Huo, Leili Gao, Lixin Guo, et al.The Lancet. Diabetes & Endocrinology|September 18, 2017
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trialRury R Holman, Ruth L Coleman, Juliana C N Chan, et al.Medicine|March 6, 2016
Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialGuogan Wang, Pengbo Wang, Yishi Li, et al.Pageof 24